Financial News Archive

Vertiv Holdings Co announced a quarterly cash dividend of $0.0625 per share for Class A common stock, payable June 25, 2026. The dividend demonstrates...

THOR reported Q3 net income of $97.2M (down 28.1% YoY) with gross margins compressed 250bps to 12.8%, citing tariffs and consumer sentiment weakness i...

FortuneX Acquisition Corporation's May 26, 2026 balance sheet audit raised substantial doubt about the company's ability to continue as a going concer...

Energy Focus entered into a securities purchase agreement dated May 29, 2026 to issue and sell securities to a purchaser under Section 4(a)(2) of the ...

Turn Therapeutics presented an investor presentation at the Jefferies Global Healthcare Conference in June 2026. The presentation included forward-loo...

Sadot Group Inc. submitted an exhibit containing corporate bylaws or charter information in an 8-K filing. The filing appears to be a routine governan...

ARCH Capital Group Ltd. is issuing $600 million of 5.250% senior notes due 2036 and $1.4 billion of 5.950% senior notes due 2056 through an underwriti...

New ERA Energy & Digital, Inc. entered into an employment agreement with Darin Rovell effective June 22, 2026, appointing him as Chief Accounting Offi...

Astrotech Corporation has entered into an ATM offering agreement with H.C. Wainwright & Co., LLC dated June 2, 2026, allowing the company to sell shar...

Upbound Group increased the aggregate share authorization under its 2026 Long-Term Incentive Plan to 4,590,636 shares of common stock as of June 2, 20...

Intuitive Machines entered into a sales agreement with 10 financial institutions to sell up to $500 million of Class A common stock through an at-the-...

GEN Restaurant Group has appointed Luke Hewko as Chief Financial Officer effective June 1, 2026, with an annual salary of $300,000. The appointment ad...

# FDA Approves Generic Tofacitinib; Somerset Therapeutics Enters Competitive JAK Inhibitor Market Somerset Therapeutics, LLC has received FDA approva...

# FDA Approves Generic Tofacitinib from Novadoz Pharmaceuticals Novadoz Pharmaceuticals LLC has received FDA approval for its generic tofacitinib cit...

Sun Pharmaceutical Industries has received FDA approval for its generic tofacitinib citrate oral formulation, a regulatory milestone expected to drive...

Breckenridge Pharmaceutical’s FDA approval for oral tofacitinib citrate is set to introduce aggressive competition to the branded market, likely press...

Aurobindo Pharma received FDA approval for its generic tofacitinib citrate oral tablets on June 3, 2026, establishing a new entrant in the JAK inhibit...

Novadoz Pharmaceuticals secured FDA approval June 3, 2026, for oral Tofacitinib Citrate tablets, positioning the firm to capitalize on a significant r...

SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnos...

Apotex has secured FDA approval for the generic version of tofacitinib (ANDA218096), slated for release on June 3, 2026, which is set to intensify com...